Recent News

• 11.03.2026 - Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
• 11.02.2026 - Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
• 10.05.2026 - Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
• 10.01.2026 - Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
• 08.26.2026 - Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
• 08.03.2026 - Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
• 08.03.2026 - Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
• 07.27.2026 - Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
• 07.22.2026 - Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
• 07.06.2026 - Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026

Recent Filings

• 11.02.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.02.2026 - 8-K Current report
• 11.02.2026 - EX-99.1 EX-99.1
• 10.30.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.24.2026 - 144 Report of proposed sale of securities